DMRA DAMORA THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about DAMORA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 6 months
Analyst view · last 6M
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #79 in the index82
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8061
Recent analyst activity · last 90 days
Our tracked history has 5 reports on DMRA from 5 analyst firms in the last 90 days (12 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Guggenheim raised its target from $40.00 (set 17 Feb 2026) to $60.00 on 25 Sep 2026.
Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Guggenheim | Brad Canino | Buy | 25 Sep 2026 | 60.00 USD |
| H.C. Wainwright | Mitchell S. Kapoor | Buy | 21 Jul 2026 | 45.00 USD |
| Jefferies | Akash Tewari | Buy | 27 Jul 2026 | 50.00 USD |
| Lifesci Capital | Sam Slutsky | Buy | 13 May 2026 | 45.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 11 Aug 2026 | 40.00 USD |
| TD Cowen | Tyler Van Buren | Buy | 24 Aug 2026 | — |
| Wedbush | David Nierengarten | Buy | 29 Sep 2026 | 40.00 USD |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:07 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.